Amend CSHB 3057 (house committee report) as follows:

(1)  On page 3, strike lines 9 through 11, and substitute the following:

(A)  qualified as a certified health care facility in accordance with the procedure for the chimeric antigen receptor T-cell therapy product license approved by the United States Food and Drug Administration; and".

(2)  On page 3, line 13, between "network" and the underlined period, insert "with respect to any other service".